Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sahar Mohseni Nodehi"'
Autor:
Sahar Mohseni Nodehi, Roland Repp, Christian Kellner, Joachim Bräutigam, Matthias Staudinger, Natalie Schub, Matthias Peipp, Martin Gramatzki, Andreas Humpe
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42426 (2012)
CD96, a cell surface antigen recently described to be preferentially expressed on acute myeloid leukemia (AML) leukemic stem cells (LSC) may represent an interesting target structure for the development of antibody-based therapeutic approaches. The v
Externí odkaz:
https://doaj.org/article/e141e20b65ef45f59621665ab7eb5d90
Autor:
Matthias Staudinger, Martin Gramatzki, Roland Repp, Matthias Peipp, Joachim Bräutigam, Andreas Humpe, Sahar Mohseni Nodehi, Natalie Schub, Christian Kellner
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42426 (2012)
PLoS ONE
PLoS ONE
CD96, a cell surface antigen recently described to be preferentially expressed on acute myeloid leukemia (AML) leukemic stem cells (LSC) may represent an interesting target structure for the development of antibody-based therapeutic approaches. The v
Autor:
Paul W. H. I. Parren, Michael Dechant, Thomas Valerius, Jan G. J. van de Winkel, Matthias Staudinger, Patrick Van Berkel, Dalia Akramiene, Christian Kellner, Anja Muskulus, Martin Gramatzki, Pia Glorius, Georg H. Fey, Matthias Peipp, Sahar Mohseni Nodehi, Roland Repp
Publikováno v:
Journal of immunological methods. 373(1-2)
Protein- or glyco-engineering of antibody molecules can be used to enhance Fc-mediated effector functions. ScFv-Fc fusion proteins (scFv-Fc) represent interesting antibody derivatives due to their relatively simple design and increased tissue penetra
Publikováno v:
Antibody Engineering ISBN: 9783642011436
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c76de6bb944798b550d79709db07b97
https://doi.org/10.1007/978-3-642-01144-3_4
https://doi.org/10.1007/978-3-642-01144-3_4
Autor:
Sahar Mohseni Nodehi, Roland Repp, Christian Kellner, Jan G. J. van de Winkel, Michel de Weers, Pia Glorius, Daniela Hallack, Martin Gramatzki, Tina Maurer, Matthias Staudinger, Matthias Peipp, Andreas Humpe, Paul W. H. I. Parren
Publikováno v:
Blood. 116:2843-2843
Abstract 2843 Natural killer group 2 member D (NKG2D) is an important activating receptor controlling cytotoxicity of natural killer (NK) cells and T cells and plays an important role in immune surveillance against tumors. For redirecting NK cells to